Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 68

1.

Generating Evidence for Genomic Diagnostic Test Development: Workshop Summary.

Institute of Medicine (US) Roundtable on Translating Genomic-Based Research for Health.

Washington (DC): National Academies Press (US); 2011.

2.

The Value of Genetic and Genomic Technologies: Workshop Summary.

Institute of Medicine (US) Roundtable on Translating Genomic-Based Research for Health.

Washington (DC): National Academies Press (US); 2010.

3.

Genome-Based Diagnostics: Demonstrating Clinical Utility in Oncology: Workshop Summary.

Roundtable on Translating Genomic-Based Research for Health, Board on Health Sciences Policy, Institute of Medicine, Center for Medical Technology Policy.

Washington (DC): National Academies Press (US); 2013 Dec 27.

4.

Genome-Based Diagnostics: Clarifying Pathways to Clinical Use: Workshop Summary.

Institute of Medicine (US).

Washington (DC): National Academies Press (US); 2012.

5.

Methods for the comparative evaluation of pharmaceuticals.

Zentner A, Velasco-Garrido M, Busse R.

GMS Health Technol Assess. 2005 Nov 15;1:Doc09.

6.

[A research roadmap for complementary and alternative medicine - what we need to know by 2020].

Fischer F, Lewith G, Witt CM, Linde K, von Ammon K, Cardini F, Falkenberg T, Fønnebø V, Johannessen H, Reiter B, Uehleke B, Weidenhammer W, Brinkhaus B.

Forsch Komplementmed. 2014;21(2):e1-16. doi: 10.1159/000360744. Epub 2014 Mar 24.

7.
8.
9.

Mental, Neurological, and Substance Use Disorders in Sub-Saharan Africa: Reducing the Treatment Gap, Improving Quality of Care: Workshop Summary.

Institute of Medicine (US) Forum on Neuroscience and Nervous System Disorders, Uganda National Academy of Sciences Forum on Health and Nutrition.

Washington (DC): National Academies Press (US); 2010.

10.

The Economics of Genomic Medicine: Workshop Summary.

Institute of Medicine (US), Roundtable on Translating Genomic-Based Research for Health.

Washington (DC): National Academies Press (US); 2013.

11.

Evidence Brief: The Quality of Care Provided by Advanced Practice Nurses.

McCleery E, Christensen V, Peterson K, Humphrey L, Helfand M.

VA Evidence-based Synthesis Program Evidence Briefs [Internet]. Washington (DC): Department of Veterans Affairs (US); 2011-.
2014 Sep.

12.

Assessing Genomic Sequencing Information for Health Care Decision Making: Workshop Summary.

Roundtable on Translating Genomic-Based Research for Health, Board on Health Sciences Policy, Institute of Medicine.

Washington (DC): National Academies Press (US); 2014 Aug 19.

13.

Funding the unfundable: mechanisms for managing uncertainty in decisions on the introduction of new and innovative technologies into healthcare systems.

Stafinski T, McCabe CJ, Menon D.

Pharmacoeconomics. 2010;28(2):113-42. doi: 10.2165/11530820-000000000-00000. Review.

PMID:
20085389
14.

Genomics-Enabled Learning Health Care Systems: Gathering and Using Genomic Information to Improve Patient Care and Research: Workshop Summary.

Roundtable on Translating Genomic-Based Research for Health, Board on Health Sciences Policy, Institute of Medicine.

Washington (DC): National Academies Press (US); 2015 Jul 8.

15.

Recommendations from the EGAPP Working Group: genomic profiling to assess cardiovascular risk to improve cardiovascular health.

Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group..

Genet Med. 2010 Dec;12(12):839-43. doi: 10.1097/GIM.0b013e3181f872c0.

PMID:
21042222
16.

How to anticipate the assessment of the public health benefit of new medicines?

Massol J, Puech A, Boissel JP; Participants inRound Table No 7, Giens XXII..

Therapie. 2007 Sep-Oct;62(5):427-35. doi: 10.2515/therapie:2007071. Epub 2008 Jan 19.

PMID:
18206104
17.

Risk management frameworks for human health and environmental risks.

Jardine C, Hrudey S, Shortreed J, Craig L, Krewski D, Furgal C, McColl S.

J Toxicol Environ Health B Crit Rev. 2003 Nov-Dec;6(6):569-720. Review.

PMID:
14698953
18.

Cost-Effectiveness and Affordability of Interventions, Policies, and Platforms for the Prevention and Treatment of Mental, Neurological, and Substance Use Disorders.

Levin C, Chisholm D.

In: Patel V, Chisholm D, Dua T, Laxminarayan R, Medina-Mora ME, editors. Mental, Neurological, and Substance Use Disorders: Disease Control Priorities, Third Edition (Volume 4). Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2016 Mar 14. Chapter 12.

19.

Telemedicine for the Medicare population: pediatric, obstetric, and clinician-indirect home interventions.

Hersh WR, Wallace JA, Patterson PK, Shapiro SE, Kraemer DF, Eilers GM, Chan BK, Greenlick MR, Helfand M.

Evid Rep Technol Assess (Summ). 2001 Aug;(24 Suppl):1-32.

20.

Promotion of evidence-informed health policymaking in Nigeria: bridging the gap between researchers and policymakers.

Uneke CJ, Ezeoha AE, Ndukwe CD, Oyibo PG, Onwe F.

Glob Public Health. 2012;7(7):750-65. doi: 10.1080/17441692.2012.666255. Epub 2012 Mar 7.

PMID:
22394290

Supplemental Content

Support Center